Correlation Between Israel China and Jerusalem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel China and Jerusalem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Jerusalem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel China Biotechnology and Jerusalem, you can compare the effects of market volatilities on Israel China and Jerusalem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Jerusalem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Jerusalem.

Diversification Opportunities for Israel China and Jerusalem

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Israel and Jerusalem is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Jerusalem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jerusalem and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Jerusalem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jerusalem has no effect on the direction of Israel China i.e., Israel China and Jerusalem go up and down completely randomly.

Pair Corralation between Israel China and Jerusalem

Assuming the 90 days trading horizon Israel China Biotechnology is expected to under-perform the Jerusalem. In addition to that, Israel China is 2.83 times more volatile than Jerusalem. It trades about -0.56 of its total potential returns per unit of risk. Jerusalem is currently generating about 0.05 per unit of volatility. If you would invest  137,400  in Jerusalem on February 1, 2024 and sell it today you would earn a total of  1,600  from holding Jerusalem or generate 1.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Israel China Biotechnology  vs.  Jerusalem

 Performance 
       Timeline  
Israel China Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Modest
Over the last 90 days Israel China Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat weak fundamental drivers, Israel China sustained solid returns over the last few months and may actually be approaching a breakup point.
Jerusalem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Modest
Over the last 90 days Jerusalem has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Jerusalem is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Israel China and Jerusalem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel China and Jerusalem

The main advantage of trading using opposite Israel China and Jerusalem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Jerusalem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jerusalem will offset losses from the drop in Jerusalem's long position.
The idea behind Israel China Biotechnology and Jerusalem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.